BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 27695068)

  • 1. Enhancing Predicted Efficacy of Tumor Treating Fields Therapy of Glioblastoma Using Targeted Surgical Craniectomy: A Computer Modeling Study.
    Korshoej AR; Saturnino GB; Rasmussen LK; von Oettingen G; Sørensen JC; Thielscher A
    PLoS One; 2016; 11(10):e0164051. PubMed ID: 27695068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of tumor position, conductivity distribution and tissue homogeneity on the distribution of tumor treating fields in a human brain: A computer modeling study.
    Korshoej AR; Hansen FL; Thielscher A; von Oettingen GB; Sørensen JCH
    PLoS One; 2017; 12(6):e0179214. PubMed ID: 28604803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Skull defect increases the tumor treating fields strength without detrimental thermogenic effect: A computational simulating research.
    Jin T; Dou Z; Zhao Y; Jiang B; Xu J; Zhang B; Wei B; Dong F; Zhang J; Sun C
    Cancer Med; 2023 Jan; 12(2):1461-1470. PubMed ID: 35861406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving Tumor Treating Fields Treatment Efficacy in Patients With Glioblastoma Using Personalized Array Layouts.
    Wenger C; Salvador R; Basser PJ; Miranda PC
    Int J Radiat Oncol Biol Phys; 2016 Apr; 94(5):1137-43. PubMed ID: 26883559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study protocol for OptimalTTF-2: enhancing Tumor Treating Fields with skull remodeling surgery for first recurrence glioblastoma: a phase 2, multi-center, randomized, prospective, interventional trial.
    Mikic N; Poulsen FR; Kristoffersen KB; Laursen RJ; Guldberg TL; Skjøth-Rasmussen J; Wong ET; Møller S; Dahlrot RH; Sørensen JCH; Korshøj AR
    BMC Cancer; 2021 Sep; 21(1):1010. PubMed ID: 34503460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Planning TTFields treatment using the NovoTAL system-clinical case series beyond the use of MRI contrast enhancement.
    Connelly J; Hormigo A; Mohilie N; Hu J; Chaudhry A; Blondin N
    BMC Cancer; 2016 Nov; 16(1):842. PubMed ID: 27809808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Skull modulated strategies to intensify tumor treating fields on brain tumor: a finite element study.
    Yang X; Liu P; Xing H; Wen X; Wang Y; Hu C; Li L; Ma W
    Biomech Model Mechanobiol; 2022 Aug; 21(4):1133-1144. PubMed ID: 35477828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computed modeling of alternating electric fields therapy for recurrent glioblastoma.
    Lok E; Hua V; Wong ET
    Cancer Med; 2015 Nov; 4(11):1697-9. PubMed ID: 26311253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The electric field distribution in the brain during TTFields therapy and its dependence on tissue dielectric properties and anatomy: a computational study.
    Wenger C; Salvador R; Basser PJ; Miranda PC
    Phys Med Biol; 2015 Sep; 60(18):7339-57. PubMed ID: 26350296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modeling Tumor Treating fields (TTFields) application within a realistic human head model.
    Wenger C; Salvador R; Basser PJ; Miranda PC
    Annu Int Conf IEEE Eng Med Biol Soc; 2015; 2015():2555-8. PubMed ID: 26736813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Importance of electrode position for the distribution of tumor treating fields (TTFields) in a human brain. Identification of effective layouts through systematic analysis of array positions for multiple tumor locations.
    Korshoej AR; Hansen FL; Mikic N; von Oettingen G; Sørensen JCH; Thielscher A
    PLoS One; 2018; 13(8):e0201957. PubMed ID: 30133493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimization of tumor treating fields using singular value decomposition and minimization of field anisotropy.
    Korshoej AR; Sørensen JCH; von Oettingen G; Poulsen FR; Thielscher A
    Phys Med Biol; 2019 Feb; 64(4):04NT03. PubMed ID: 30641498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Review on Tumor-Treating Fields (TTFields): Clinical Implications Inferred From Computational Modeling.
    Wenger C; Miranda PC; Salvador R; Thielscher A; Bomzon Z; Giladi M; Mrugala MM; Korshoej AR
    IEEE Rev Biomed Eng; 2018; 11():195-207. PubMed ID: 29993870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Guidelines for Burr Hole Surgery in Combination With Tumor Treating Fields for Glioblastoma: A Computational Study on Dose Optimization and Array Layout Planning.
    Cao F; Mikic N; Wong ET; Thielscher A; Korshoej AR
    Front Hum Neurosci; 2022; 16():909652. PubMed ID: 35782043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resection of malignant brain tumors in eloquent cortical areas: a new multimodal approach combining 5-aminolevulinic acid and intraoperative monitoring.
    Feigl GC; Ritz R; Moraes M; Klein J; Ramina K; Gharabaghi A; Krischek B; Danz S; Bornemann A; Liebsch M; Tatagiba MS
    J Neurosurg; 2010 Aug; 113(2):352-7. PubMed ID: 19911888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct-Current Electric Field Distribution in the Brain for Tumor Treating Field Applications: A Simulation Study.
    Sun YS
    Comput Math Methods Med; 2018; 2018():3829768. PubMed ID: 29681995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. End-to-end workflow for finite element analysis of tumor treating fields in glioblastomas.
    Timmons JJ; Lok E; San P; Bui K; Wong ET
    Phys Med Biol; 2017 Oct; 62(21):8264-8282. PubMed ID: 29023236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maintenance Therapy With Tumor-Treating Fields Plus Temozolomide vs Temozolomide Alone for Glioblastoma: A Randomized Clinical Trial.
    Stupp R; Taillibert S; Kanner AA; Kesari S; Steinberg DM; Toms SA; Taylor LP; Lieberman F; Silvani A; Fink KL; Barnett GH; Zhu JJ; Henson JW; Engelhard HH; Chen TC; Tran DD; Sroubek J; Tran ND; Hottinger AF; Landolfi J; Desai R; Caroli M; Kew Y; Honnorat J; Idbaih A; Kirson ED; Weinberg U; Palti Y; Hegi ME; Ram Z
    JAMA; 2015 Dec; 314(23):2535-43. PubMed ID: 26670971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Magnetic resonance imaging volumetric assessment of the extent of contrast enhancement and resection in oligodendroglial tumors.
    Sankar T; Moore NZ; Johnson J; Ashby LS; Scheck AC; Shapiro WR; Smith KA; Spetzler RF; Preul MC
    J Neurosurg; 2012 Jun; 116(6):1172-81. PubMed ID: 22424566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simplified realistic human head model for simulating Tumor Treating Fields (TTFields).
    Wenger C; Bomzon Z; Salvador R; Basser PJ; Miranda PC
    Annu Int Conf IEEE Eng Med Biol Soc; 2016 Aug; 2016():5664-5667. PubMed ID: 28269540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.